Our 3rd annual
Pre-Filled Syringes East Coast conference returns to New Jersey in April 2016.
With exponential growth of biologics and protein-based products, demand for
pre-filled syringes (PFS) is growing on an exponential scale. As such, the global
pre-filled syringes (PFS) market is presenting lucrative opportunities for both pharma and device companies- the investment forecast expects to exceed $6.6.bn by 2020. According to a recent study led by Brigham and Women's Hospital (BWH) in Boston, switching to
PFS can also cut related costs by almost 50%, equivalent to $162,000 in savings!
While we have witnessed booming investments in
PFS, pharma and device manufacturers still need to overcome a number of challenges to commercialize
PFS. It also faces fierce competition with innovative drug delivery platforms. Hence, developing a drug-compatible and patient-centric
PFS remain top priority amongst market participant.
Emulating on previous success, the 3rd Annual
Pre-Filled Syringes East Coast will delve further into the core issues of
PFS including
- human factor engineering
- PFS material selection and GMP compliance
- compatibility and injectability considerations for complex biologics and combination product
and many more!
Join us today and don't miss out on this must-attend event!
Benefits of Attending
Building on previous success, the
PFS East Coast 2016 meeting will:
- Address PFS regulatory differences and requirements in the US and EU
- Encapsulate the 'why' and 'how' of human factor engineering for a more patient-centric device
- Update you on latest technology developments - from manufacturing to material selection - to ensure both compliance and commercial competitiveness
- Delve further into the core issues around safety and integrity of PFS through QbD
- Provide you the best platform to network with and learn from your industry colleagues and PFS expert
Plus Two Interactive Half-Day Post-Conference Workshops | Wednesday April 27th 2016
The Pre-Filled Syringe as a System: Human Factors Considerations for PFS Development and Regulatory SubmissionWorkshop Leader: Melanie Turieo, Associate Director, Medical Technology, Cambridge Consultants
8.30 – 12.30
Combination Rule and CMC Considerations for PFS and AutoinjectorsWorkshop Leader: Ravi S. Harapanhalli, Ph.D., Principal, FDAPharma Consulting LLC
13.30 – 17.30
Speakers
- Bobbijo Redler, Principal Scientist, Merck & Co.
- Carsten Worsoe, Principal Scientist, CMC Analytical Support, Novo Nordisk
- Evan Goulet, Director, Sterilization Operations, Noxilizer, Inc.
- Isabelle Delcroix, Business Development Director, Nemera
- Jason Lipman, Associate Director, Regulatory Affairs, Medical Devices & Combination Products, Janssen R&D LLC
- Ken Wong, Deputy Director, MTech/ Process Technology – Extractables & Leachables, Sanofi Pasteur
- Kenichiro Usuda, Researcher, Advanced Business Development Division, MITSUBISHI GAS CHEMICAL COMPANY, INC
- Kevin Constable, Senior Director of Technology Development, Terumo Americas Holding, Inc
- Mathias Romacker, Drug Delivery Devices, Pfizer
- Melanie Turieo, Associate Director, US Medical Technology Division / Group Leader, Human Factors & Industrial Design, Cambridge Consultants Ltd
- Mohammed Umar, Principal Technical Manager, Quality Engineering, Genentech
- Padam Sharma, Injectables, Sterile Manufacturing & Dev. Global Pharmaceutical Technology, Allergan Inc
- Paolo Mangiagalli, Senior Director, Head PFS/ Primary Container Platform, Sanofi S A
- Ravi S. Harapanhalli, Principal, FDAPharma Consulting
- Roja Narwal, Scientist II, Formulation Sciences, MedImmune
- Royce Brockett, Senior Product Manager, PFS Platform, West Pharmaceutical Services, Inc.
- Shawn Davis, Principal Engineer, Device Strategy, Amgen
- Stephen Barat, Executive Director, Non-Clinical & Translational Sciences, Allergan
- Tiffany McIntire, Human Factors Engineer, Eli Lilly & Company
- Toshiro Katayama, Product Manager, Zeon Chemicals L.P.
Please fill in your name and email to receive the conference agenda of this event.
The agenda is available as PDF under downloads at the right side of the page.
Venue
Renaissance Woodbridge Hotel
515 US Highway 1 South, 08830
Iselin, NJ, United States
Who Should Attend
Chiefs, Principals, VPs, Directors, Heads, Managers of:
- Pre-Filled Syringes/ PFS
- Device Manufacturing
- Scientist
- CMC
- Manufacturing
- Fill/Finish
- Human Factor Engineering
- Injectables
- Drug Delivery
- Sterilization
- Commercial
- Biologics
Venue
Renaissance Woodbridge Hotel515 US Highway 1 South
Iselin, New Jersey 08830
USA
